Section 17: Funding & Investment Strategy
Strategic roadmap for securing capital to build and scale Clinical Trial Navigator, a patient-centric healthtech platform addressing a $2B recruitment bottleneck.
1. Funding Path Assessment
Recommended Primary Path: Pre-Seed VC ($400K-$600K)
Secondary Path: Accelerator (e.g., Y Combinator or Rock Health)
Rationale (248 words): Clinical Trial Navigator is at pre-product stage with strong technical feasibility (public APIs + LLMs) and massive TAM (50M+ chronic patients, $2B recruitment market). Healthtech demands credibility via expert validation, HIPAA compliance, and clinical advisors—best achieved through institutional pre-seed VCs with domain focus (e.g., Rock Health). This provides $500K+ for 2 FTE engineers, legal/SOC2 setup ($100K+), and early marketing to hit MVP launch + 1K beta users. Bootstrapping risks slow validation in a regulated space; angels alone may lack healthtech networks for partnerships. Accelerators offer network/brand (YC alumni effect in health) as backup for coachable solo/duo founders, with 7% dilution but $500K SAFE. Pre-seed fits: vision-led (patient pain validated via public data), low capex ($500K runway), milestones to seed (MVP, 500 waitlist, 20% conversion). Avoid crowdfunding (B2C sensitivity) or grants initially (slow for speed). Hybrid: Angels for bridge if traction emerges. This path balances dilution (15-20%), runway (18 months), and defensibility via pharma B2B moat.
2. Funding Stage & Target Amount
Current Stage: Pre-Product (MVP build underway).
Recommended Raise: $500K (range: $400K-$600K)
- Valuation Target: $4M pre-money
- Dilution: 11-13% (SAFE preferred)
- Runway: 18 months at $28K/mo burn
- Milestones: MVP launch, 1K waitlist, HIPAA setup, 100 beta users, $2K pilot B2B revenue
3. Use of Funds Breakdown
Milestone Allocation:
Dev
4. Investor Targeting
Angel Investors (Target 20+)
VC Firms (Pre-Seed/Seed)
Accelerators
Intro Strategy: Build 50-investor list; prioritize 10 warm intros via founder network/LinkedIn. Track in Notion/CRM.
5. Pitch Deck Framework (12 Slides)
- Title: Clinical Trial Navigator – AI-Powered Trial Matching for Patients
- Problem: 450K trials, jargon overload, missed opportunities (50M patients)
- Solution: Smart matching + plain language + tracker (screenshots)
- Market: $2B recruitment TAM; 20% CAGR digital health
- Product: Demo matching engine, dashboard
- Traction: Waitlist prototype, advisor LOIs
- Business Model: Freemium $10/mo + B2B leads ($50/qualified)
- Competition: Matrix vs. ClinicalTrials.gov (poor UX)
- GTM: Patient forums → Premium → Pharma pilots
- Team: [Founders] + clinical advisor
- Financials: $1M ARR Yr3 (20% margins)
- Ask: $500K @ $4M for MVP → PMF
Tailor visuals: Patient journey infographic, match score demo GIF. Use YC template.
6. Key Metrics for Investors
Top Diligence Qs: Unfair advantage (AI + FHIR)? Risk mit (disclaimers)? Why now (AI maturity)?
7. Fundraising Timeline (3 Months)
- ✅ Deck/data room
- ✅ 50 targets
- ✅ Practice pitches
8. Term Sheet Considerations
Red Flags: Participating prefs, board control. Use YC SAFE.
9. Alternative Funding
- Grants: SBIR Phase I ($275K, health innovation, nih.gov)
- RBF: Lighter Capital (revenue share post-MRR)
- Credits: AWS Activate ($25K healthtech)
10-11. Financial Scenarios & Decision Framework
A: Bootstrap
$0 raise; solo MVP in 6mos → $5K MRR Yr1. Pros: Control. Cons: Slow regulatory. Prob: Medium.
B: Pre-Seed VC (Recommended)
$500K @ $4M; 18mo → PMF + $20K MRR. Path: Seed in 12mos. Best for speed/moat.
C: Accelerator
YC $500K; aggressive → Series A. Risk: High burn.
Decision: Raise if scaling B2B/pharma fast (winner-take-all recruitment). Bootstrap if niche patient focus. Hybrid Reco: Prototype → Angels $100K → Pre-seed on traction. Next: Build waitlist for leverage.
Actionable Next Steps
- Finalize deck this week
- Secure 5 warm intros
- Launch waitlist landing page
- Target Rock Health/YC apps